BioCrossroads is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's existing research and corporate strengths while encouraging new business development.
This post is sponsored by BioCrossroads. Indiana’s life sciences industry has a $50 billion total impact on the state’s economy, according to recently updated data gathered by the Indiana Business Research Center at the Indiana University Kelley School of Business and BioCrossroads, Indiana’s initiative for investment, development and advancement of the state’s signature life sciences […]
This post is sponsored by BioCrossroads. Indiana has moved up the life sciences ladder and is now at the top of the leading national list. According to a Battelle/Biotechnology Industry Organization (BIO) Report “State Bioscience Industry Development 2012” released today at the BIO International Conference in Boston, Indiana is one of only two states (along […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
This post is sponsored by BioCrossroads. At a press conference today announcing the Indiana Seed Fund II (ISFII), BioCrossroads also launched the inaugural BioCrossroads New Venture Competition presented by Krieg DeVault, an early stage business competition open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus […]
This post is sponsored by BioCrossroads. BioCrossroads announced today the formation of the Indiana Seed Fund II (the Fund), an early-stage capital fund focused on identifying, creating and developing the next generation of Indiana-based life sciences companies. The $8.25 million fund is a follow-on to the Indiana Seed Fund I, a $6 million fund that […]
Welcome to Indiana! BioCrossroads is excited to partner with MedCity News to spread the word about Indiana’s life sciences sector. BioCrossroads’ mission is to grow, advance and invest in Indiana’s life sciences sector. We have raised more than one-quarter billion dollars (in both grant funds and capital investments) for life sciences opportunities, organized four venture capital funds, and launched eight new enterprises that showcase some of our leading life sciences assets. Those enterprises include, for example, the Indiana Health Information Exchange to advance our pioneering work in health information technology, or OrthoWorx to capitalize on our dominance of nearly a third of the global orthopedics industry from the small and picturesque community of Warsaw, Indiana. Collaborating with industry, academia and government partners, we are busy writing a 21st-century chapter for our continuing story of more than a century of life sciences start-ups and strengths.
This post is sponsored by BioCrossroads. According to a report recently released by BioCrossroads, the medical devices industry is one of Indiana’s most valuable economic assets employing over 20,000 people, and generating more than $10 billion of annual economic output. The first of its kind report, From Hearts to Hips: Indiana’s Leadership in Medical Devices, […]
Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.